Literature DB >> 1721350

Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.

I Felser1, S Wagner, J Depee, N Johnson, S Staschak, A Jain, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721350      PMCID： PMC2958703     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors:  J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.

Authors:  S Todo; J J Fung; A Tzakis; A J Demetris; A Jain; M Alessiani; S Takaya; R Day; R Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066
  2 in total
  1 in total

1.  Reliability and validity of the ESRD Symptom Checklist--Transplantation Module in Norwegian kidney transplant recipients.

Authors:  Knut Stavem; Rüdiger Ganss
Journal:  BMC Nephrol       Date:  2006-11-16       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.